Login / Signup

Vaccination against SARS-CoV-2: a human enhancement story.

Niklas Alexander DöblerClaus-Christian Carbon
Published in: Translational medicine communications (2021)
 We argue that qualifying vaccination technology as Human Enhancement does not provide convincing arguments to reject vaccination. By examining the Human Enhancement debate and the similarities to the issue of vaccination shown here, policymakers can learn valuable lessons regarding mass vaccination programs' current and future handling.
Keyphrases
  • endothelial cells
  • sars cov
  • induced pluripotent stem cells
  • pluripotent stem cells
  • current status